Drug intelligence / Profile preview

ENDS S-TA-U001

Development stage
Unknown
Lead developer
NJOY
Modality
Small Molecules
Administration
Inhalation
01

Overview

ENDS S-TA-U001 is a research electronic nicotine delivery system (ENDS), commonly referred to as an e-cigarette or vaporizer. It was developed as a test product for clinical studies evaluating the pharmacokinetics (PK) and pharmacodynamics (PD) of nicotine delivery in smokers and e-cigarette users. The device is designed to deliver nicotine via inhalation, mimicking the experience of smoking traditional cigarettes but without combustion. The primary indication studied was cigarette smoking, with comparisons made against both combustible cigarettes and FDA-approved smoking cessation products such as the Nicorette Inhalator. The developer and lead sponsor for clinical trials involving this product is NJOY.

Brand names
ENDS S-TA-U001
Other names
Research ENDS S-TA-U001Electronic Nicotine Delivery System S-TA-U001
02

Targets

α4β2 nAChR (Nicotinic acetylcholine receptor alpha4 beta2 subtype)CHRNA7 (α7 nicotinic receptor)Muscle-type nicotinic acetylcholine receptor

Beyond the preview

Go deeper on ENDS S-TA-U001.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ENDS S-TA-U001.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call